Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abiomed's slows patient enrolment in artificial heart trial:

This article was originally published in Clinica

Executive Summary

Abiomed, of Danvers, Massachusetts, has said that despite slowing the rate of patient enrolment for a human trial of its fully-implantable artificial heart, AbioCor, the firm expects to seek FDA approval for the device by the end of 2003. The delay in enrolment is reported to be due to Abiomed focusing on identifying and addressing potential problems in order to maximise the clinical success with the nine remaining AbioCor devices awaiting implantation.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065934

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel